CANDICE VICENCIO: Open Payments
NPI 1003442880 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$143 in 7 payments from 7 companies in 2025. Trend: 2023 $363 · 2024 $1,284 · 2025 $143
Food & beverage: $143
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: REXULTI, TRELEGY ELLIPTA, Wegovy, JARDIANCE, NA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
